Kintayl Capital »

Esperion Therapeutics shares owned by Kintayl Capital

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Kintayl Capital from 13F filings

Historical chart of Kintayl Capital investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Kintayl Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Kintayl Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 400k 3.16

More positions owned by Kintayl Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Essential Utils (WTRG)
Ncr Atleos Corporation Com Shs (NATL)
Silicon Laboratories (SLAB)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Allied Gold Corp Com New (AAUC)
Electronic Arts (EA)
Orla Mining LTD New F (ORLA)
Dominion Resources (D)
AvalonBay Communities (AVB)
Kenvue (KVUE)
Valaris Cl A (VAL)
AES Corporation (AES)
Northwestern Energy Group In Com New (NWE)
Equitable Holdings (EQH)

View all positions for Kintayl Capital

Top funds holding Esperion Therapeutics

Glazer Capital
BlackRock
Vanguard Capital Management
Trium Capital
Goldman Sachs Group
Two Sigma Investments
State Street Corporation
Geode Capital Management
CNH Partners
Oddo Bhf Asset Management Sas
Balyasny Asset Management
FMR
Beryl Capital Management
PenderFund Capital Management
UBS Group

View all funds holding Esperion Therapeutics